loader
Please Wait
Applying Filters...

Find excipient solutions to address Detalan formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1DKSH

02 2Gangwal Healthcare

03 1ACG Worldwide

04 2Actylis

05 2Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

06 20Corel Pharma Chem

07 6Gangwal Chemicals

08 4Ideal Cures Pvt Ltd

09 14Kerry

10 4Kima Chemical

11 6Lonza Capsugel

12 1Microlex e.U

13 1Novo Excipients

14 1Qianhao Chemical (Hebei) Co., Ltd

15 1Qualicaps

16 11Seppic

17 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

18 3The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Grade : Topical

Brand Name : BORIC ACID

Excipient Details : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.

Pharmacopoeia Ref : EP

Technical Specs : 99.9 % Boric Acid (H3BO3)

Grade : Topical

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Ingredient(s) : Boric Acid Excipient

Dosage Form : Cream / Lotion / Ointment

Category : Topical

Brand : BORIC ACID

Applications : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.

Pharmacopoeia Ref : EP

Technical Specs : 99.9 % Boric Acid (H3BO3)

Grade : Topical

arrow

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

06

arrow
2024 ACI Convention
Not Confirmed

11

arrow
2024 ACI Convention
Not Confirmed

15

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

16

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

20

arrow
2024 ACI Convention
Not Confirmed

25

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ZEPHYR™

Applications : The number of inhalation formulas for nasal and pulmonary drug delivery continues to grow, driven by the prevalence of respiratory diseases. Capsugel® offers inhalation drug-delivery capabilities for inhalable powder medication.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : Size # 00el - 4

Grade : Inhalation

arrow
blank

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

30

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Vcaps® Plus

Excipient Details : An immediate-release HPMC capsule without gelling agents. Vcaps® Plus offer excellent dissolution profile with pH-independent performance, standard or low-moisture content, great machinability and visual quality.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...

Technical Specs : "Water content – less than 9%, can be customized; Size # 00el - 4

Grade : Oral and Inhalation

arrow

Brand : VCAPS® PLUS

Applications : An immediate-release HPMC capsule without gelling agents. Vcaps® Plus offer excellent dissolution profile with pH-independent performance, standard or low-moisture content, great machinability and visual quality.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : "Water content – less than 9%, can be customized; Size # 00el - 4

Grade : Oral and Inhalation

arrow
blank

32

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

35

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : DRCAPS®

Applications : DRcaps® are made with an innovative HPMC formulation that can help protect sensitive ingredients from the low pH environment of the stomach. The low-moisture level of DRcaps® provides enhanced stability for hygroscopic ingredients.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : Size # 0-1

Grade : Oral

arrow
blank

40

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® HML C2910

Excipient Details : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow

Brand : MICROLEX® HML C2910

Applications : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/JPE

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow
blank

46

arrow
2024 ACI Convention
Not Confirmed